Isoxazol-3(2H)-one analogs as therapeutic agents

Details for Australian Patent Application No. 2010235236 (hide)

Owner AstraZeneca AB

Inventors Bostrom, Jonas; Cheng, Leifeng; Fex, Tomas; Karle, Michael; Pettersen, Daniel; Schell, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2010235236

PCT Pub. Number WO2010/117323

Priority 61/167,224 07.04.09 US; 61/171,956 23.04.09 US

Filing date 6 April 2010

Wipo publication date 14 October 2010

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

20 October 2011 PCT application entered the National Phase

  PCT publication WO2010/117323 Priority application(s): WO2010/117323

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010235238-New methods for treatment of inflammatory diseases

2010235233-Method and apparatus for detecting pharmaceuticals in a sample